145 related articles for article (PubMed ID: 2033425)
1. Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice?
Hoppe RT
J Clin Oncol; 1991 Jun; 9(6):897-901. PubMed ID: 2033425
[No Abstract] [Full Text] [Related]
2. Hodgkin's disease in adults: the challenge.
Lister TA
Postgrad Med J; 1985 Feb; 61(712):103-7. PubMed ID: 3838586
[No Abstract] [Full Text] [Related]
3. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
4. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
5. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Diehl V
J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
[No Abstract] [Full Text] [Related]
6. Hodgkin's disease.
Gassmann W; Schmitz N; Kayser W; Löffler H
Cancer Treat Rev; 1984 Dec; 11(4):311-4. PubMed ID: 6549501
[No Abstract] [Full Text] [Related]
7. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
8. Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
Hoppe RT
Blood; 1983 Jul; 62(1):32-6. PubMed ID: 6688032
[No Abstract] [Full Text] [Related]
9. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy and survival in advanced Hodgkin's disease.
Canellos GP; Young RC; Berard CW; DeVita VT
Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
[No Abstract] [Full Text] [Related]
11. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
12. Prognostic factors in children with Hodgkin disease.
Celkan T; Yildiz I
Pediatr Blood Cancer; 2008 Nov; 51(5):712; author reply 712-3. PubMed ID: 18668513
[No Abstract] [Full Text] [Related]
13. Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
Hoppe RT
Blood; 1991 May; 77(10):2093-5. PubMed ID: 1709367
[No Abstract] [Full Text] [Related]
14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
15. Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
Brace K; Serpick AA; Block JB; Wiernik PH
Oncology; 1973; 27(6):484-92. PubMed ID: 4582588
[No Abstract] [Full Text] [Related]
16. Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
Fuller LM; Gamble JF
JAMA; 1973 Jan; 223(2):168-9. PubMed ID: 4739457
[No Abstract] [Full Text] [Related]
17. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
18. Current trend in the treatment of Hodgkin's disease.
Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
20. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
Berényi E; Szegedi G
Orv Hetil; 1984 Nov; 125(45):2737-40, 2743. PubMed ID: 6548560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
